Published in J Immunol on June 15, 1990
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med (1993) 4.80
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13
Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension (2009) 1.86
Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med (1993) 1.76
Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease. Infect Immun (1994) 1.38
Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proc Natl Acad Sci U S A (1993) 1.32
Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection. J Virol (1997) 1.24
Human double-negative (CD4-CD8-) T cells bearing alpha beta T cell receptor possess both helper and cytotoxic activities. Clin Exp Immunol (1991) 0.86
Definition of unique traits of human CD4-CD8- alpha beta T cells. Clin Exp Immunol (1993) 0.82
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 7.75
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A (1982) 7.16
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (1995) 6.85
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
The structure of a beta-(1 leads to 3)-D-glucan from yeast cell walls. Biochem J (1973) 2.98
Antibody-forming cells in human colostrum after oral immunisation. Nature (1975) 2.76
Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell (1993) 2.74
A lymphotoxin-beta-specific receptor. Science (1994) 2.73
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J Immunol (1978) 2.60
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods (1984) 2.38
TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J Biol Chem (1996) 2.23
Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells. J Immunol (1983) 2.13
Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus. Arch Dermatol (1997) 2.12
The structure of a beta-(1--6)-D-glucan from yeast cell walls. Biochem J (1973) 2.02
Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol (1998) 2.02
Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol (2009) 2.01
Novel T-lymphocyte population in combined immunodeficiency with features of graft-versus-host disease. N Engl J Med (1989) 1.99
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology (2001) 1.94
The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem (2000) 1.84
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J Cell Biol (2000) 1.80
A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med (1995) 1.76
Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proc Natl Acad Sci U S A (1997) 1.76
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.76
Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol (1993) 1.73
Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J Immunol (2001) 1.73
Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol (1999) 1.68
Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol (2001) 1.65
CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem (1998) 1.64
A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem (2001) 1.57
The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. J Immunol (1979) 1.56
The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years. Br J Haematol (1981) 1.54
Phospholipase A2 activating protein and idiopathic inflammatory bowel disease. Gut (1996) 1.48
Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol (1999) 1.45
Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med (1995) 1.45
Immunologic factors in human milk during the first year of lactation. J Pediatr (1982) 1.45
Interferon gamma (IFN-gamma) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb Pathog (1991) 1.44
Antibody production by human colostral cells. I. Immunoglobulin class, specificity, and quantity. Scand J Immunol (1975) 1.43
The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J Virol (1997) 1.43
Purine metabolism in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1976) 1.43
Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J Biol Chem (2000) 1.42
Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J Immunol (1995) 1.41
Leprosy: a 'common' and curable cause of peripheral neuropathy with skin lesions. J R Coll Physicians Edinb (2015) 1.39
Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity. J Immunol (1983) 1.39
Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. Immunity (2001) 1.37
Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect Immun (1993) 1.36
Bacterial lipoprotein and lipopolysaccharide act synergistically to induce lethal shock and proinflammatory cytokine production. J Immunol (1997) 1.32
Detection of pharmacovigilance-related adverse events using electronic health records and automated methods. Clin Pharmacol Ther (2012) 1.29
Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels. Br J Haematol (1982) 1.29
Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect Immun (1986) 1.26
The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism. Infect Immun (2004) 1.25
Tumor necrosis factor-alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb Pathog (1993) 1.24
Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol (2001) 1.24
Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells. J Immunol (1986) 1.23
Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis. J Virol (1991) 1.22
Physicochemical characterization of fluid phase (SC5b-9) and membrane derived (MC5b-9) attack complexes of human complement purified by immunoadsorbent affinity chromatography or selective detergent extraction. Mol Immunol (1981) 1.22
Fetal hemoglobin and clinical severity of homozygous sickle cell disease in early childhood. J Pediatr (1981) 1.21
Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst. J Immunol (1998) 1.21
Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium. J Immunol (1993) 1.19
Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect Immun (1998) 1.19
A novel X-linked combined immunodeficiency disease. J Clin Invest (1990) 1.18
Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes. Am J Clin Pathol (1985) 1.18
A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: purification, immunochemical properties and its utility as a general second-antibody reagent. J Immunol Methods (1984) 1.18
Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study. Postgrad Med J (2006) 1.15
Isolation and characterization of the mountain cedar (Juniperus ashei) pollen major allergen, Jun a 1. J Allergy Clin Immunol (1999) 1.14
Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J Pediatr (1977) 1.13
Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ (1998) 1.13
Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol (2000) 1.12
The dermatopathology of Cowden's syndrome. Br J Dermatol (1979) 1.12
Anti-inflammatory systems in human milk. Adv Exp Med Biol (1990) 1.12
Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol (2000) 1.11
Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem (1992) 1.10
The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveA. Mol Immunol (2000) 1.10
Early splenomegaly in homozygous sickle-cell disease: An indicator of susceptibility to infection. Lancet (1978) 1.10
Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J Immunol (1996) 1.09
Homology modeling and characterization of IgE binding epitopes of mountain cedar allergen Jun a 3. Biophys J (2000) 1.09
Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways. J Biol Chem (2000) 1.09
T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly. Blood (1999) 1.08
Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol (1982) 1.07
Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis. Nature (1977) 1.07
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol. J Biol Chem (1997) 1.07
Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor. J Biol Chem (1997) 1.07
Tumor necrosis factor (TNF alpha) regulates intestinal mucus production during salmonellosis. Cell Immunol (1993) 1.07
In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease. J Immunol (1988) 1.06
Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett (1995) 1.05
Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol (1996) 1.05
Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology (2001) 1.05
Suppression by apoptotic cells defines tumor necrosis factor-mediated induction of glomerular mesangial cell apoptosis by activated macrophages. Am J Pathol (2001) 1.05
Varicella-zoster virus infection of a human CD4-positive T-cell line. Virology (2000) 1.04
Milk- and soy protein-induced enterocolitis: evidence for lymphocyte sensitization to specific food proteins. Gastroenterology (1985) 1.04
Direct cytolysis by partially-purified preparations of immune interferon. Int J Cancer (1982) 1.04
Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha/beta. Cell Immunol (1983) 1.03
Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis. J Virol (2000) 1.03
Variable expression of pathogenesis-related protein allergen in mountain cedar (Juniperus ashei) pollen. J Immunol (2000) 1.03
Molecular cloning of the mountain cedar (Juniperus ashei) pollen major allergen, Jun a 1. J Allergy Clin Immunol (1999) 1.02